MBX Biosciences, Inc.·4

Nov 7, 8:20 AM ET

Hoerter Steven L. 4

4 · MBX Biosciences, Inc. · Filed Nov 7, 2025

Insider Transaction Report

Form 4
Period: 2025-11-06
Transactions
  • Award

    Stock option (right to buy)

    2025-11-06+100,000100,000 total
    Exercise: $24.74Exp: 2035-11-05Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]The grant will vest in equal monthly installments over a one-year period from the date of grant, subject to the non-employee director's continued services to the Company.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4